» Articles » PMID: 16482740

Systemic Lupus Erythematosus in a Multiethnic U.S. Cohort (LUMINA) XXVII: Factors Predictive of a Decline to Low Levels of Disease Activity

Overview
Journal Lupus
Publisher Sage Publications
Specialty Rheumatology
Date 2006 Feb 18
PMID 16482740
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to examine factors predictive of a decline to low levels of disease activity in a cohort of systemic lupus erythematosus (SLE) patients. Patients with SLE of Hispanic (from Texas or Puerto Rico), African-American or Caucasian ethnicity from a multiethnic cohort were included. A decline to low levels of disease activity was defined as a score < or =5 as per the Systemic Lupus Activity Measure-Revised (SLAM-R) at any annual study visit if preceded by a SLAM-R > or =8. Using Generalized Estimating Equation (GEE), socioeconomic-demographic, behavioral, function, psychological, laboratory and clinical data [disease manifestations, number of ACR criteria accrued at diagnosis and damage accrual as per the Systemic Lupus International Collaborating Clinics (SLICC) Damage Index (SDI)] from the visit preceding that meeting the definition were examined as predictors of decline to low levels of disease activity. Two-hundred and eighty-seven patients (67 Hispanics from Texas, 32 Hispanics form Puerto Rico, 120 African-Americans and 68 Caucasians), accounting for 632 visits were analyzed. In the GEE multivariable analysis, higher degrees of social support (OR = 1.208, 95% CI 1.059-1.379; P = 0.005) were predictive of a decline to low levels of disease activity, while the number of ACR criteria accrued at diagnosis (OR = 0.765, 95% CI 0.631-0.927; P = 0.006) and damage (OR = 0.850, 95% CI 0.743-0.972, P = 0.018) were negatively associated. These data suggest that a decline to low levels of disease activity in lupus patients seems to be multifactorial; this study also underscores the importance of social support for lupus patients.

Citing Articles

Self-reported disease severity in women with systemic lupus erythematosus.

Dima A, Caraiola S, Delcea C, Ionescu R, Jurcut C, Badea C Rheumatol Int. 2018; 39(3):533-539.

PMID: 30415452 DOI: 10.1007/s00296-018-4203-1.


I too, am America: a review of research on systemic lupus erythematosus in African-Americans.

Williams E, Bruner L, Adkins A, Vrana C, Logan A, Kamen D Lupus Sci Med. 2016; 3(1):e000144.

PMID: 27651918 PMC: 5013381. DOI: 10.1136/lupus-2015-000144.


Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus.

Bonakdar Z, Mohtasham N, Karimifar M J Res Med Sci. 2012; 16 Suppl 1:S427-32.

PMID: 22247729 PMC: 3252779.


Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX.

Zhang J, Gonzalez L, Roseman J, Vila L, Reveille J, Alarcon G Lupus. 2010; 19(6):727-33.

PMID: 20118158 PMC: 3964002. DOI: 10.1177/0961203309359289.


Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus.

Kong K, Tan A, Thong B, Lian T, Cheng Y, Teh C Clin Exp Immunol. 2009; 156(1):134-40.

PMID: 19175619 PMC: 2673751. DOI: 10.1111/j.1365-2249.2009.03880.x.